Salt Restriction in Diabetes

被引:2
|
作者
Clifton, Peter M. [1 ]
Keogh, Jennifer B. [2 ]
机构
[1] Univ S Australia, Sch Pharm & Med Sci, P5-16 Playford Bldg,GPO Box 2471, Adelaide, SA 5001, Australia
[2] Univ S Australia, Sch Pharm & Med Sci, P1-23 Playford Bldg City East Campus,IPC CEA 19, Adelaide, SA 5000, Australia
关键词
Salt; Sodium; Diet; Type; 2; diabetes; URINARY SODIUM-EXCRETION; BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; POTASSIUM EXCRETION; DIETARY QUALITY; WEIGHT-LOSS; MORTALITY; RISK; HYDROCHLOROTHIAZIDE; SUPPLEMENTATION;
D O I
10.1007/s11892-015-0629-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are no long-term interventions examining the effects of salt reduction in people with diabetes, and these are urgently required. Sodium reduction is controversial as it appears that an intake below 2.5 g and above 6 g/day of salt is associated with increased cardiovascular disease risk. However, pre-existing illness leading to a lower salt intake may confound the findings. Only a few studies have prospectively collected data on the sodium intake and excretion of people with diabetes and examined hard end points. In addition, future studies need to collect more data on food intake as well as coexistent illnesses to address potential confounding. The World Health Organization recommends a reduction to less than 5 g/day salt in adults. Given that the available evidence suggests that the salt intake of people with type 2 diabetes is generally well above 6 g/day it seems reasonable to ensure individuals with diabetes have an intake below 6 g/day. However, such recommendations need to be individualized.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Salt Restriction in Diabetes
    Peter M. Clifton
    Jennifer B. Keogh
    [J]. Current Diabetes Reports, 2015, 15
  • [2] Salt Restriction
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2012, 54 (1384): : 13 - 13
  • [3] SALT RESTRICTION
    VONWITT, RJ
    VONWITT, VC
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1983, 2 (12) : 604 - 604
  • [4] Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes
    Allen, TJ
    Waldron, MJ
    Casley, D
    Jerums, G
    Cooper, ME
    [J]. DIABETES, 1997, 46 (01) : 119 - 124
  • [5] DIETARY SALT RESTRICTION
    GIFFORD, RW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (09): : 1198 - 1198
  • [6] SALT RESTRICTION IN HYPERTENSION
    VERDONK, G
    [J]. LANCET, 1980, 2 (8196): : 703 - 703
  • [7] SALT RESTRICTION IN HYPERTENSION
    GHOOI, RB
    VALANJU, VV
    RAJARSHI, MG
    [J]. MEDICAL HYPOTHESES, 1993, 41 (02) : 137 - 140
  • [8] THERAPEUTIC ASPECTS OF SALT RESTRICTION
    GROLLMAN, A
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1961, 91 (24) : 734 - &
  • [9] SALT RESTRICTION IN THE TREATMENT OF HYPERTENSION
    MACGREGOR, GA
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 : 25 - 37
  • [10] SALT RESTRICTION FOR BORDERLINE HYPERTENSION
    HART, JT
    [J]. JOURNAL OF THE ROYAL COLLEGE OF GENERAL PRACTITIONERS, 1984, 34 (260): : 140 - &